ANRO (STOCKS)
Alto Neuroscience Inc.
$21.180000
-0.290000 (-1.35%)
Prev close: $21.470000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Amit Etkin
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $743.99M
- Employees
- 76
- P/E (TTM)
- -8.65
- P/B (TTM)
- 3.09
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
9
Strong Buy
7
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.80 | $-0.55 | -0.2527 | -46.17% |
|
Dec 2025 (Q4)
|
$-0.58 | $-0.54 | -0.0386 | -7.13% |
|
Sep 2025 (Q3)
|
$-0.52 | $-0.68 | +0.1611 | +23.65% |
|
Jun 2025 (Q2)
|
$-0.65 | $-0.63 | -0.0247 | -3.95% |
Financial Statements
| Assets | $276.26M |
| Current Assets | $269.13M |
| Prepaid Expenses | $3.47M |
| Other Current Assets | $265.66M |
| Noncurrent Assets | $7.13M |
| Fixed Assets | $2.23M |
| Other Non-current Assets | $4.90M |
| Liabilities | $32.89M |
| Current Liabilities | $13.12M |
| Accounts Payable | $3.37M |
| Wages | $2.00M |
| Other Current Liabilities | $7.75M |
| Noncurrent Liabilities | $19.78M |
| Equity | $243.37M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $243.37M |
| Liabilities And Equity | $276.26M |